Skip to main content

Table 1 Clinical characteristics of patients

From: Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer

Clinical characteristics Frozen samples (N = 108) Paraffin samples (N = 132) All (N = 240)
Age 48.12 ± 11.47 53.32 ± 8.79 50.98 ± 10.40
FIGO stage    
I–II 23 23
III–IV 85 132 217
Grade (serous)    
3 74 132 206
1 17 17
Grade (mucinous and endometrioid)    
3 11 11
2 1 1
1 5 5
Histology types    
Serous 91 132 223
Mucinous 14 14
Endometrioid 3 3
Surgical debulking    
Optimal 76 96 172
Suboptimal 32 36 68
Chemotherapy outcome    
Chemoresistant 55 56 111
Chemosensitive 53 76 129
Postoperative chemotherapy scheme    
TP (paclitaxel plus cisplatin) 57 58 115
TC (paclitaxel plus carboplatin) 51 74 125